Alternatives to JCR Pharmaceuticals

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

A global oncology company developing and commercializing innovative cancer treatments.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Biotech company developing next-generation gene writing tools for advanced therapies.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Pioneering vision restoration therapies for severe retinal degenerations.